FDA Inspection 710676 — Octapharma AB
The FDA completed an inspection of Octapharma AB on Jan 20, 2011 in Stockholm. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Biologics.
Inspection details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jan 20, 2011
- Fiscal Year
- 2011
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Stockholm (Sweden)